A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Clinical trial NCT00622713 · COMPLETED
Trial details
- NCT number
- NCT00622713
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.